Login / Signup
Refractory Type I pityriasis rubra pilaris treated with tildrakizumab.
Gaetano Licata
A Gambardella
Giulia Calabrese
F Pagliuca
R Alfano
G Argenziano
Published in:
Clinical and experimental dermatology (2021)
Keyphrases
</>
newly diagnosed